speb/financial-data huggingface dataset:
Financial ratios for DBG.PA — annual report dated 2024-09-30
Total revenue: 4017777777.7777777
Gross profit: 1306000000
Operating income: 193888888.8888889
Net income: 85222222.22222222
Capital expenditures: 103111111.1111111
Operating cash flow: 364777777.7777778
Depreciation & amortization: 176888888.8888889
Net tangible assets: 836333333.3333333
Owner earnings: 159000000
Return on net tangible assets (%): 19.011558389796733
Capex to operating income (%): 53.18051575931232
Buffett classification: The Good
Stock price: 5.633333333333334
P/E ratio: 10.473179644067798
Shares outstanding: 158440410
Book value: 1149111111.111111
P/B ratio: 0.7767287552697739
Market cap (USD): 892547643.0000001
Debt to equity: 0.8759427576871013
Current ratio: 1.08434974283615
Quick ratio: 0.8267450404114621
Effective tax rate (%): 27.773584905660382
Interest coverage ratio: 3.9125560538116595
COGS to revenue (%): 67.49446902654867
Free cash flow (dilution-adjusted): 202000000
Buyback yield (%): 0.062243798402541455
Retained earnings: 83111111.1111111
Inventory turnover: 13.922418710781518
Receivables turnover: 13.168244719592135
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.26663480431204
FCF margin (%): 5.027654867256637
Revenue growth (%): 5.148454239363322
Rule of 40 score: 10.17610910661996
Financial ratios for DBG.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 836333333.3333333
Buffett classification: The Gruesome
Stock price: 5.633333333333334
Shares outstanding: 158440410
Book value: 1149111111.111111
P/B ratio: 0.7767287552697739
Market cap (USD): 892547643.0000001
Debt to equity: 0.8759427576871013
Current ratio: 1.08434974283615
Quick ratio: 0.8267450404114621
Buyback yield (%): 0
Retained earnings: 83111111.1111111
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBG.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 865434782.6086956
Buffett classification: The Gruesome
Stock price: 5.782608695652174
Shares outstanding: 158440410
Book value: 1171195652.173913
P/B ratio: 0.7822765486774942
Market cap (USD): 916198892.6086956
Debt to equity: 0.8258932714617169
Current ratio: 1.0871153575944918
Quick ratio: 0.8045524799775186
Buyback yield (%): 0
Retained earnings: 68695652.17391305
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBG.PA — annual report dated 2025-09-30
Total revenue: 3935529411.764706
Gross profit: 1347882352.9411764
Operating income: 190117647.05882353
Net income: 145882352.94117647
Capital expenditures: 110117647.05882353
Operating cash flow: 271647058.8235294
Depreciation & amortization: 189176470.5882353
Net tangible assets: 988941176.4705882
Owner earnings: 224941176.47058827
Return on net tangible assets (%): 22.74565786343089
Capex to operating income (%): 57.920792079207914
Buffett classification: The Good
Stock price: 6.094117647058823
P/E ratio: 6.618720353225806
Shares outstanding: 158440410
Book value: 1322823529.4117649
P/B ratio: 0.7299193559231588
Market cap (USD): 965554498.5882353
Debt to equity: 0.7524902170046247
Current ratio: 1.1037173015144561
Quick ratio: 0.8254551017286217
Effective tax rate (%): 32.7455919395466
Interest coverage ratio: 4.367567567567567
COGS to revenue (%): 65.75092670094463
Free cash flow (dilution-adjusted): 152235294.11764705
Buyback yield (%): 0.4630073436383645
Retained earnings: 143529411.7647059
Inventory turnover: 12.091808686091259
Receivables turnover: 11.639526791927628
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.441287087338068
FCF margin (%): 3.8682291043883774
Revenue growth (%): -2.047110879750121
Rule of 40 score: 1.8211182246382562
Financial ratios for DBG.PA — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 988941176.4705882
Buffett classification: The Gruesome
Stock price: 6.094117647058823
Shares outstanding: 158440410
Book value: 1322823529.4117649
P/B ratio: 0.7299193559231588
Market cap (USD): 965554498.5882353
Debt to equity: 0.7524902170046247
Current ratio: 1.1037173015144561
Quick ratio: 0.8254551017286217
Buyback yield (%): 0
Retained earnings: 143529411.7647059
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFCH.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.006621621621621622
Shares outstanding: 164487673
Market cap (USD): 1089175.132027027
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFCH.L — annual report dated 2022-12-31
Total revenue: 24590361.445783135
Net income: 11760240.963855423
Capital expenditures: 1254216.8674698796
Operating cash flow: -4106024.0963855423
Depreciation & amortization: 843373.4939759036
Net tangible assets: 114893975.90361446
Owner earnings: 11349397.590361448
Return on net tangible assets (%): 9.878148528764081
Buffett classification: The Gruesome
Stock price: 0.0040963855421686755
P/E ratio: 0.057295163220981465
Shares outstanding: 164487673
Book value: 115950602.40963852
P/B ratio: 0.005811137773667642
Market cap (USD): 673804.9255421688
Debt to equity: 0.004104365174201728
Effective tax rate (%): -648.5429447852761
COGS to revenue (%): 0
SG&A to revenue (%): 8.97109260166585
Free cash flow (dilution-adjusted): -6193975.903614459
Buyback yield (%): 0
Retained earnings: -22608433.73493976
Receivables turnover: 6.545862732520847
Capitalized R&D asset: 0
FCF margin (%): -25.18863302302793
Rule of 40 score: -25.18863302302793
Financial ratios for DFCH.L — annual report dated 2023-12-31
Total revenue: 48022784.81012658
Net income: 3993670.8860759493
Capital expenditures: 529113.9240506329
Operating cash flow: -47736708.86075949
Depreciation & amortization: 1106329.1139240505
Net tangible assets: 126324050.63291138
Owner earnings: 4570886.075949367
Return on net tangible assets (%): 3.6183814982564435
Buffett classification: The Gruesome
Stock price: 0.002911392405063291
P/E ratio: 0.11991177429477021
Shares outstanding: 164487673
Book value: 127106329.11392403
P/B ratio: 0.003767618538251639
Market cap (USD): 478888.16189873416
Debt to equity: 0.11378891389646863
Effective tax rate (%): 31.008090968729498
COGS to revenue (%): 0
SG&A to revenue (%): 6.871738099003638
Free cash flow (dilution-adjusted): -49559493.67088608
Buyback yield (%): 17.709798096911918
Retained earnings: 31291139.24050633
Receivables turnover: 4.888917525773196
Capitalized R&D asset: 0
FCF margin (%): -103.19995782592653
Revenue growth (%): 95.29108962471857
Rule of 40 score: -7.908868201207966
Financial ratios for DFCH.L — annual report dated 2024-12-31
Total revenue: 56733750
Net income: 17526250
Capital expenditures: 496250
Operating cash flow: 11501250
Depreciation & amortization: 1157500
Net tangible assets: 143005000
Owner earnings: 18187500
Return on net tangible assets (%): 12.71808678018251
Buffett classification: The Gruesome
Stock price: 0.004625
P/E ratio: 0.04340663220169745
Shares outstanding: 164487673
Book value: 144192500
P/B ratio: 0.005275971271910813
Market cap (USD): 760755.487625
Debt to equity: 0.08946373771173952
Effective tax rate (%): 26.49155919052113
COGS to revenue (%): 0
SG&A to revenue (%): 7.662987198977681
Free cash flow (dilution-adjusted): 8995000
Buyback yield (%): 23.332069618601984
Retained earnings: 49623750
Receivables turnover: 5.898245614035088
Capitalized R&D asset: 0
FCF margin (%): 15.854760173617995
Revenue growth (%): 18.139233749802315
Rule of 40 score: 33.99399392342031
Financial ratios for DFCH.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 143005000
Buffett classification: The Gruesome
Stock price: 0.004625
Shares outstanding: 164487673
Book value: 144192500
P/B ratio: 0.005275971271910813
Market cap (USD): 760755.487625
Debt to equity: 0.08946373771173952
Buyback yield (%): 0
Retained earnings: 49623750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DFCH.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 159998630.13698632
Buffett classification: The Gruesome
Stock price: 0.005342465753424658
Shares outstanding: 164487673
Book value: 161130136.98630154
P/B ratio: 0.005453788945377253
Market cap (USD): 878769.7598630138
Debt to equity: 0.10947502656748129
Buyback yield (%): 0
Retained earnings: 64219178.08219178
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNLI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.6
Shares outstanding: 158709737
Market cap (USD): 7078454270.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNLI — annual report dated 2022-12-31
Total revenue: 108463000
Operating income: -340744000
Net income: -325991000
Capital expenditures: 17833000
Operating cash flow: -244716000
Depreciation & amortization: 10383000
Net tangible assets: 1042430000
Owner earnings: -333441000
Return on net tangible assets (%): -31.98689600260929
Buffett classification: The Gruesome
Stock price: 27.81
Shares outstanding: 158709737
Book value: 1042430000
P/B ratio: 4.2340663507094
Market cap (USD): 4413717785.97
Debt to equity: 0.057893575587809255
Current ratio: 3.770915196113453
Quick ratio: 3.770915196113453
COGS to revenue (%): 0
R&D to revenue (%): 330.7413588043849
SG&A to revenue (%): 83.41554262743978
Free cash flow (dilution-adjusted): -362396000
Buyback yield (%): 0
Retained earnings: -970987000
Receivables turnover: 11.685304891187243
Capitalized R&D asset: 358732000
ROCI (R&D-adjusted, %): -6.9818352425434504
FCF margin (%): -334.11946931211565
Rule of 40 score: -334.11946931211565
Financial ratios for DNLI — annual report dated 2023-12-31
Total revenue: 45527685.95
Operating income: -196699000
Net income: -145224000
Capital expenditures: 12939000
Operating cash flow: -357991000
Depreciation & amortization: 16726000
Net tangible assets: 1030954000
Owner earnings: -141437000
Return on net tangible assets (%): -13.719040810744223
Buffett classification: The Gruesome
Stock price: 21.46
Shares outstanding: 158709737
Book value: 1030954000
P/B ratio: 3.3036497807079654
Market cap (USD): 3405910956.02
Debt to equity: 0.0506724839323578
Current ratio: 13.645931112307968
Quick ratio: 13.645931112307968
COGS to revenue (%): 0
R&D to revenue (%): 931.0290895643467
SG&A to revenue (%): 227.01351461944884
Free cash flow (dilution-adjusted): -479032000
Buyback yield (%): 0
Retained earnings: -1116211000
Receivables turnover: 13.312188874269006
Capitalized R&D asset: 664226440
ROCI (R&D-adjusted, %): -1.936161356002311
FCF margin (%): -1052.1773509993209
Revenue growth (%): -58.02468496169201
Rule of 40 score: -1110.2020359610128
Financial ratios for DNLI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.13
Shares outstanding: 158709737
Market cap (USD): 4623214638.809999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNLI — quarterly report dated 2024-12-31
Capital expenditures: 5092000
Buffett classification: The Gruesome
Stock price: 20.38
Shares outstanding: 158709737
Market cap (USD): 3234504440.06
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DNLI — annual report dated 2024-12-31
Total revenue: 0
Operating income: -501878000
Net income: -422773000
Capital expenditures: 15912000
Operating cash flow: -347694000
Depreciation & amortization: 8992000
Net tangible assets: 1229684000
Owner earnings: -429693000
Return on net tangible assets (%): -34.94336756434986
Buffett classification: The Gruesome
Stock price: 20.38
Shares outstanding: 158709737
Book value: 1229684000
P/B ratio: 2.6303541723402106
Market cap (USD): 3234504440.06
Debt to equity: 0.039609363055874515
Current ratio: 8.457615842204133
Quick ratio: 8.457615842204133
Free cash flow (dilution-adjusted): -466484000
Buyback yield (%): 0
Retained earnings: -1538984000
Receivables turnover: 0
Capitalized R&D asset: 798818480
ROCI (R&D-adjusted, %): -24.070711393264663
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for DNLI — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -145580000
Net income: -132970000
Capital expenditures: 5078000
Operating cash flow: -131468000
Depreciation & amortization: 3212000
Net tangible assets: 1122686000
Owner earnings: -134836000
Return on net tangible assets (%): -12.010125716362367
Buffett classification: The Gruesome
Stock price: 13.6
Shares outstanding: 158709737
Book value: 1122686000
P/B ratio: 1.9225789073703599
Market cap (USD): 2158452423.2
Debt to equity: 0.04331754381901974
Current ratio: 9.563198624247635
Quick ratio: 9.563198624247635
Free cash flow (dilution-adjusted): -161706000
Buyback yield (%): 0
Retained earnings: -1671954000
Capitalized R&D asset: 116227000
ROCI (R&D-adjusted, %): -5.255514487871228
Rule of 40 score: 0
Financial ratios for DNLI — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -134963000
Net income: -124119000
Capital expenditures: 4278000
Operating cash flow: -75298000
Depreciation & amortization: 3956000
Net tangible assets: 1027053000
Owner earnings: -124441000
Return on net tangible assets (%): -12.116317268923805
Buffett classification: The Gruesome
Stock price: 13.99
Shares outstanding: 158709737
Book value: 1027053000
P/B ratio: 2.1618643055713775
Market cap (USD): 2220349220.63
Debt to equity: 0.04533164306028997
Current ratio: 10.26506473966856
Quick ratio: 10.26506473966856
Free cash flow (dilution-adjusted): -104963000
Buyback yield (%): 0
Retained earnings: -1796073000
Capitalized R&D asset: 180568090
ROCI (R&D-adjusted, %): -8.380741244343326
Rule of 40 score: 0
Financial ratios for DNLI — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -137434000
Net income: -126902000
Capital expenditures: 1378000
Operating cash flow: -107296000
Depreciation & amortization: 3862000
Net tangible assets: 926197000
Owner earnings: -124418000
Return on net tangible assets (%): -13.433211293061841
Buffett classification: The Gruesome
Stock price: 14.52
Shares outstanding: 158709737
Book value: 926197000
P/B ratio: 2.488094197282004
Market cap (USD): 2304465381.24
Debt to equity: 0.047942284416814133
Current ratio: 9.79076165331795
Quick ratio: 9.79076165331795
Free cash flow (dilution-adjusted): -131053000
Buyback yield (%): 0
Retained earnings: -1922975000
Capitalized R&D asset: 209111230
ROCI (R&D-adjusted, %): -12.126965481850291
Rule of 40 score: 0
Financial ratios for DNLI — annual report dated 2025-12-31
Total revenue: 0
Operating income: -555342000
Net income: -512540000
Capital expenditures: 9502000
Operating cash flow: -412600000
Depreciation & amortization: 14812000
Net tangible assets: 1013761000
Owner earnings: -507230000
Return on net tangible assets (%): -50.03447558152266
Buffett classification: The Gruesome
Stock price: 16.51
Shares outstanding: 158709737
Book value: 1013761000
P/B ratio: 2.5847292980002194
Market cap (USD): 2620297757.8700004
Debt to equity: 0.03625706650778635
Current ratio: 9.157588636617827
Quick ratio: 9.157588636617827
Free cash flow (dilution-adjusted): -521735000
Buyback yield (%): 0
Retained earnings: -2051524000
Receivables turnover: 0
Capitalized R&D asset: 824271880
ROCI (R&D-adjusted, %): -29.37795130824791
Rule of 40 score: 0
Financial ratios for DNLI — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -137365000
Net income: -128549000
Capital expenditures: 1524000
Operating cash flow: -98538000
Depreciation & amortization: 3782000
Net tangible assets: 1013761000
Owner earnings: -126291000
Return on net tangible assets (%): -12.457670003087513
Buffett classification: The Gruesome
Stock price: 16.51
Shares outstanding: 158709737
Book value: 1013761000
P/B ratio: 2.5847292980002194
Market cap (USD): 2620297757.8700004
Debt to equity: 0.03625706650778635
Current ratio: 9.157588636617827
Quick ratio: 9.157588636617827
Free cash flow (dilution-adjusted): -124013000
Buyback yield (%): 0
Retained earnings: -2051524000
Receivables turnover: 0
Capitalized R&D asset: 200101180
ROCI (R&D-adjusted, %): -11.255403726733318
Rule of 40 score: 0
Financial ratios for DRX.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.06891891891891891
Shares outstanding: 336588225
Market cap (USD): 23197296.587837834
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRX.L — annual report dated 2022-12-31
Total revenue: 9367831325.301205
Gross profit: 1232891566.2650602
Operating income: 290481927.7108434
Net income: 102530120.48192772
Capital expenditures: 195542168.6746988
Operating cash flow: 250240963.8554217
Depreciation & amortization: 288433734.9397591
Net tangible assets: 896746987.9518073
Owner earnings: 195421686.74698797
Return on net tangible assets (%): 21.792288055891444
Capex to operating income (%): 67.31646619659892
Buffett classification: The Good
Stock price: 0.07325301204819278
P/E ratio: 0.24047666368977674
Shares outstanding: 336588225
Book value: 1595421686.7469883
P/B ratio: 0.015454284911644764
Market cap (USD): 24656101.30120482
Debt to equity: 1.2037456577556258
Current ratio: 1.0858617878815324
Quick ratio: 0.9282220813332124
Effective tax rate (%): -5.633802816901409
Interest coverage ratio: 3.1516339869281045
COGS to revenue (%): 86.83909302534951
Free cash flow (dilution-adjusted): 28192771.08433735
Buyback yield (%): 0
Retained earnings: 233493975.90361446
Inventory turnover: 19.396725079000287
Receivables turnover: 28.110267534345624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.470572448404497
FCF margin (%): 0.30095301788998496
Rule of 40 score: 0.30095301788998496
Financial ratios for DRX.L — annual report dated 2023-12-31
Total revenue: 9788860759.49367
Gross profit: 2472911392.405063
Operating income: 1287215189.8734176
Net income: 711645569.6202531
Capital expenditures: 544050632.9113923
Operating cash flow: 1057721518.9873418
Depreciation & amortization: 284810126.5822785
Net tangible assets: 1864303797.4683545
Owner earnings: 452405063.29113925
Return on net tangible assets (%): 24.266702878870177
Capex to operating income (%): 42.26570950929295
Buffett classification: The Good
Stock price: 0.055569620253164545
P/E ratio: 0.02628285855122732
Shares outstanding: 336588225
Book value: 2510126582.2784815
P/B ratio: 0.007451448854009074
Market cap (USD): 18704079.844936706
Debt to equity: 0.7872415532022187
Current ratio: 1.1234372754706137
Quick ratio: 0.9661349810796572
Effective tax rate (%): 29.570567553992966
Interest coverage ratio: 8.834926151172892
COGS to revenue (%): 74.7374954740599
Free cash flow (dilution-adjusted): 481772151.89873415
Buyback yield (%): 1009.7302891101403
Retained earnings: 843544303.7974683
Inventory turnover: 17.599269183922047
Receivables turnover: 23.01547619047619
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.73974232414508
FCF margin (%): 4.921636579941034
Revenue growth (%): 4.494417326402143
Rule of 40 score: 9.416053906343176
Financial ratios for DRX.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1992625000
Buffett classification: The Gruesome
Stock price: 0.076
Shares outstanding: 336588225
Book value: 2608875000
P/B ratio: 0.009805262843179532
Market cap (USD): 25580705.099999998
Debt to equity: 0.6196157347515692
Current ratio: 1.2012377850162868
Quick ratio: 1.0044951140065146
Buyback yield (%): 0
Retained earnings: 1397625000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRX.L — annual report dated 2024-12-31
Total revenue: 7703125000
Gross profit: 2345625000
Operating income: 1142625000
Net income: 658250000
Capital expenditures: 474125000
Operating cash flow: 1074375000
Depreciation & amortization: 302250000
Net tangible assets: 1992625000
Owner earnings: 486375000
Return on net tangible assets (%): 24.408757292516153
Capex to operating income (%): 41.4943660431025
Buffett classification: The Good
Stock price: 0.076
P/E ratio: 0.03886168644132169
Shares outstanding: 336588225
Book value: 2608875000
P/B ratio: 0.009805262843179532
Market cap (USD): 25580705.099999998
Debt to equity: 0.6196157347515692
Current ratio: 1.2012377850162868
Quick ratio: 1.0044951140065146
Effective tax rate (%): 30.249535439341653
Interest coverage ratio: 8.503255813953489
COGS to revenue (%): 69.54969574036511
Free cash flow (dilution-adjusted): 572500000
Buyback yield (%): 563.9015790850895
Retained earnings: 1397625000
Inventory turnover: 14.19205298013245
Receivables turnover: 13.103338294705507
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.720676769773718
FCF margin (%): 7.432048681541582
Revenue growth (%): -21.307236978223752
Rule of 40 score: -13.87518829668217
Financial ratios for DRX.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 2085479452.0547945
Buffett classification: The Gruesome
Stock price: 0.09150684931506849
Shares outstanding: 336588225
Market cap (USD): 30800127.986301366
Current ratio: 1.0170821544867346
Quick ratio: 0.8733251481343083
Buyback yield (%): 0
Retained earnings: 1769589041.0958905
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFOI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.89
Shares outstanding: 6369222
Market cap (USD): 190376045.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFOI — annual report dated 2022-12-31
Total revenue: 5968000
Gross profit: -318000
Operating income: -8957000
Net income: -10279000
Capital expenditures: 16000
Operating cash flow: -6713000
Depreciation & amortization: 159000
Net tangible assets: -477000
Owner earnings: -10136000
Buffett classification: The Gruesome
Stock price: 2.24
Shares outstanding: 6369222
Book value: -477000
Market cap (USD): 14267057.280000001
Debt to equity: -12.80083857442348
Current ratio: 0.9114019632519507
Quick ratio: 0.22225018877422603
Interest coverage ratio: -9.38888888888889
COGS to revenue (%): 105.328418230563
R&D to revenue (%): 24.983243967828418
SG&A to revenue (%): 119.7721179624665
Free cash flow (dilution-adjusted): -6871000
Buyback yield (%): 0
Retained earnings: -149020000
Inventory turnover: 1.147918188458729
Receivables turnover: 6.70561797752809
Capitalized R&D asset: 1491000
ROCI (R&D-adjusted, %): -389.76994615761134
FCF margin (%): -115.13069705093835
Rule of 40 score: -115.13069705093835
Financial ratios for EFOI — annual report dated 2023-12-31
Total revenue: 5717000
Gross profit: 223000
Operating income: -3971000
Net income: -4293000
Capital expenditures: 69000
Operating cash flow: -2439000
Depreciation & amortization: 33000
Net tangible assets: 3051000
Owner earnings: -4329000
Return on net tangible assets (%): -141.88790560471975
Buffett classification: The Gruesome
Stock price: 1.51
Shares outstanding: 6369222
Book value: 3051000
P/B ratio: 3.1522534316617503
Market cap (USD): 9617525.22
Debt to equity: 0.7682726974762373
Current ratio: 1.446858762399622
Quick ratio: 0.7479137143756889
Interest coverage ratio: -10.45
COGS to revenue (%): 96.09935280741648
R&D to revenue (%): 10.267622879132412
SG&A to revenue (%): 63.09253104775232
Free cash flow (dilution-adjusted): -2552000
Buyback yield (%): 0
Retained earnings: -153315000
Inventory turnover: 1.237666141022753
Receivables turnover: 3.226297968397291
Capitalized R&D asset: 1585970
ROCI (R&D-adjusted, %): -75.00808038805489
Rosenberg metric: 0.36284372904091217
FCF margin (%): -44.638796571628475
Revenue growth (%): -4.205764075067024
Rule of 40 score: -48.8445606466955
Financial ratios for EFOI — quarterly report dated 2024-09-30
Capital expenditures: 19000
Buffett classification: The Gruesome
Stock price: 1.19
Shares outstanding: 6369222
Market cap (USD): 7579374.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFOI — annual report dated 2024-12-31
Total revenue: 4860000
Gross profit: 699000
Operating income: -1842000
Net income: -1582000
Capital expenditures: 19000
Operating cash flow: -1297000
Depreciation & amortization: 37000
Net tangible assets: 2915000
Owner earnings: -1564000
Return on net tangible assets (%): -53.653516295025725
Buffett classification: The Gruesome
Stock price: 1.19
Shares outstanding: 6369222
Book value: 2915000
P/B ratio: 2.6001283636363635
Market cap (USD): 7579374.18
Debt to equity: 0.13481989708404804
Current ratio: 2.1060171919770774
Quick ratio: 0.7703643061809251
Interest coverage ratio: -368.4
COGS to revenue (%): 85.61728395061728
R&D to revenue (%): 10.781893004115227
SG&A to revenue (%): 41.50205761316872
Free cash flow (dilution-adjusted): -1320000
Buyback yield (%): 0
Retained earnings: -154897000
Inventory turnover: 1.275206864848299
Receivables turnover: 6.044776119402985
Capitalized R&D asset: 1409320
ROCI (R&D-adjusted, %): -47.73221035954965
Rosenberg metric: 0.8109028960817717
FCF margin (%): -27.160493827160494
Revenue growth (%): -14.99037956970439
Rule of 40 score: -42.15087339686488
Financial ratios for EFOI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.19
Shares outstanding: 6369222
Market cap (USD): 7579374.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFOI — quarterly report dated 2025-03-31
Total revenue: 616000
Gross profit: 194000
Operating income: -268000
Net income: -268000
Capital expenditures: 5000
Operating cash flow: -272000
Depreciation & amortization: 9000
Net tangible assets: 2843000
Owner earnings: -264000
Return on net tangible assets (%): -9.285965529370383
Buffett classification: The Gruesome
Stock price: 1.84
Shares outstanding: 6369222
Book value: 2843000
P/B ratio: 4.122183777699613
Market cap (USD): 11719368.48
Debt to equity: 0.12697854379176926
Current ratio: 2.107218235542423
Quick ratio: 0.7425073870831574
COGS to revenue (%): 68.5064935064935
R&D to revenue (%): 8.116883116883116
SG&A to revenue (%): 66.88311688311688
Free cash flow (dilution-adjusted): -273000
Buyback yield (%): 0
Retained earnings: -155165000
Inventory turnover: 0.1305289205072688
Receivables turnover: 1.0476190476190477
Capitalized R&D asset: 50000
ROCI (R&D-adjusted, %): -7.547978985740324
FCF margin (%): -44.31818181818182
Rule of 40 score: -44.31818181818182
Financial ratios for EFOI — quarterly report dated 2025-06-30
Total revenue: 1143000
Gross profit: 147000
Operating income: -224000
Net income: -231000
Capital expenditures: 0
Operating cash flow: -215000
Depreciation & amortization: 10000
Net tangible assets: 2812000
Owner earnings: -221000
Return on net tangible assets (%): -7.859174964438122
Buffett classification: The Gruesome
Stock price: 2.45
Shares outstanding: 6369222
Book value: 2812000
P/B ratio: 5.54928659317212
Market cap (USD): 15604593.9
Debt to equity: 0.11593172119487909
Current ratio: 2.4149171270718233
Quick ratio: 0.8939226519337017
COGS to revenue (%): 87.13910761154857
R&D to revenue (%): 6.474190726159231
SG&A to revenue (%): 25.984251968503933
Free cash flow (dilution-adjusted): -215000
Buyback yield (%): 0
Retained earnings: -155396000
Inventory turnover: 0.3617871413003996
Receivables turnover: 1.190625
Capitalized R&D asset: 107500
ROCI (R&D-adjusted, %): -6.181015452538632
Rosenberg metric: -0.94
FCF margin (%): -18.810148731408574
Revenue growth (%): 85.55194805194806
Rule of 40 score: 66.74179932053949
Financial ratios for EFOI — quarterly report dated 2025-09-30
Total revenue: 826000
Gross profit: 147000
Operating income: -175000
Net income: -172000
Capital expenditures: 36000
Operating cash flow: -55000
Depreciation & amortization: 9000
Net tangible assets: 3140000
Owner earnings: -199000
Return on net tangible assets (%): -6.337579617834395
Buffett classification: The Gruesome
Stock price: 2.78
Shares outstanding: 6369222
Book value: 3140000
P/B ratio: 5.638992726114649
Market cap (USD): 17706437.16
Debt to equity: 0.09267515923566878
Current ratio: 2.503380135205408
Quick ratio: 0.9370774830993239
COGS to revenue (%): 82.20338983050848
R&D to revenue (%): 9.927360774818402
SG&A to revenue (%): 29.055690072639223
Free cash flow (dilution-adjusted): -104000
Buyback yield (%): 0
Retained earnings: -155568000
Inventory turnover: 0.22543160690571049
Receivables turnover: 1.2421052631578948
Capitalized R&D asset: 148080
ROCI (R&D-adjusted, %): -4.72422230534256
Rosenberg metric: 0
FCF margin (%): -12.590799031477
Revenue growth (%): -27.73403324584427
Rule of 40 score: -40.32483227732127
Financial ratios for EFOI — quarterly report dated 2025-12-31
Total revenue: 975000
Gross profit: 184000
Operating income: -357000
Net income: -356000
Capital expenditures: 0
Operating cash flow: -862000
Depreciation & amortization: 9000
Net tangible assets: 4109000
Owner earnings: -347000
Return on net tangible assets (%): -8.444877099050863
Buffett classification: The Gruesome
Stock price: 2.31
Shares outstanding: 6369222
Book value: 4109000
P/B ratio: 3.580652913117547
Market cap (USD): 14712902.82
Debt to equity: 0.05281090289608177
Current ratio: 5.042299349240781
Quick ratio: 1.8644251626898047
COGS to revenue (%): 81.12820512820514
R&D to revenue (%): 21.128205128205128
SG&A to revenue (%): 34.35897435897436
Free cash flow (dilution-adjusted): -987000
Buyback yield (%): 0
Retained earnings: -155924000
Inventory turnover: 0.26996587030716723
Receivables turnover: 1.8536121673003803
Capitalized R&D asset: 285360
ROCI (R&D-adjusted, %): -6.0743470263276365
Rosenberg metric: 0.45121951219512196
FCF margin (%): -101.23076923076924
Revenue growth (%): 18.038740920096853
Rule of 40 score: -83.19202831067238
Financial ratios for EFOI — annual report dated 2025-12-31
Total revenue: 3560000
Gross profit: 672000
Operating income: -1024000
Net income: -1027000
Capital expenditures: 41000
Operating cash flow: -1404000
Depreciation & amortization: 37000
Net tangible assets: 4109000
Owner earnings: -1031000
Return on net tangible assets (%): -25.091263081041614
Buffett classification: The Gruesome
Stock price: 2.31
Shares outstanding: 6369222
Book value: 4109000
P/B ratio: 3.580652913117547
Market cap (USD): 14712902.82
Debt to equity: 0.05281090289608177
Current ratio: 5.042299349240781
Quick ratio: 1.8644251626898047
COGS to revenue (%): 81.12359550561797
R&D to revenue (%): 11.573033707865168
SG&A to revenue (%): 36.067415730337075
Free cash flow (dilution-adjusted): -1579000
Buyback yield (%): 0
Retained earnings: -155924000
Inventory turnover: 0.985665529010239
Receivables turnover: 6.768060836501901
Capitalized R&D asset: 956790
ROCI (R&D-adjusted, %): -21.76734794123918
Rosenberg metric: -0.05152671755725191
FCF margin (%): -44.353932584269664
Revenue growth (%): -26.74897119341564
Rule of 40 score: -71.1029037776853
Financial ratios for EOG.V — annual report dated 2022-03-31
Total revenue: 2844.8
Operating income: -3149724
Net income: -5245859.2
Capital expenditures: 0
Operating cash flow: -3701910.4
Depreciation & amortization: 0
Net tangible assets: 7575125.6
Owner earnings: -5245859.2
Return on net tangible assets (%): -69.25111842369981
Buffett classification: The Gruesome
Stock price: 0.496
Shares outstanding: 349709027
Book value: 32177552.8
P/B ratio: 5.390580149774472
Market cap (USD): 173455677.392
Debt to equity: 0
Current ratio: 1.0339561655644867
Quick ratio: 1.0339561655644867
COGS to revenue (%): 0
SG&A to revenue (%): 32494.431946006745
Free cash flow (dilution-adjusted): -3713506.4
Buyback yield (%): 0
Retained earnings: -41126929.6
Receivables turnover: 0.012459792990840862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.788575344983972
FCF margin (%): -130536.64229471315
Rule of 40 score: -130536.64229471315
Financial ratios for EOG.V — annual report dated 2023-03-31
Total revenue: 49311.85185185185
Operating income: -28417251.11111111
Net income: -27077595.555555552
Capital expenditures: 1184434.074074074
Operating cash flow: -26513662.962962963
Net tangible assets: 7259680.740740741
Owner earnings: -28262029.629629627
Return on net tangible assets (%): -389.3012742423424
Buffett classification: The Gruesome
Stock price: 0.2518518518518518
Shares outstanding: 349709027
Book value: 37520436.2962963
P/B ratio: 2.347383846065598
Market cap (USD): 88074866.05925925
Debt to equity: 0
Current ratio: 1.239332761604991
Quick ratio: 1.239332761604991
COGS to revenue (%): 0
SG&A to revenue (%): 6736.600021030179
Free cash flow (dilution-adjusted): -29896834.07407407
Buyback yield (%): 0
Retained earnings: -65158085.92592592
Receivables turnover: 0.03280130355753544
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -75.73806148388583
FCF margin (%): -60628.09030959427
Revenue growth (%): 1633.4031162771319
Rule of 40 score: -58994.687193317135
Financial ratios for EOG.V — annual report dated 2024-03-31
Total revenue: 0
Operating income: -3588327.407407407
Net income: -15657702.962962963
Capital expenditures: 3703703.7037037034
Operating cash flow: -3951088.148148148
Net tangible assets: 1370148.8888888888
Owner earnings: -19361406.666666664
Return on net tangible assets (%): -1413.0877909456717
Buffett classification: The Gruesome
Stock price: 0.10294117647058824
Shares outstanding: 349709027
Book value: 22235659.259259257
P/B ratio: 1.618996686449672
Market cap (USD): 35999458.66176471
Debt to equity: 0
Current ratio: 2.4851095706295796
Quick ratio: 2.4851095706295796
Free cash flow (dilution-adjusted): -4021973.333333333
Buyback yield (%): 0
Retained earnings: -80815788.88888888
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.137715394757972
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for EOG.V — quarterly report dated 2024-09-30
Operating income: -1209180.7407407407
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.14814814814814814
Shares outstanding: 349709027
Market cap (USD): 51808744.74074074
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EOG.V — quarterly report dated 2024-12-31
Total revenue: 36420.27972027972
Operating income: -687476.2237762238
Net income: -638622.3776223776
Capital expenditures: 126191.6083916084
Operating cash flow: -1188411.1888111888
Net tangible assets: 3828640.5594405597
Owner earnings: -764813.9860139859
Return on net tangible assets (%): -19.97612400903313
Buffett classification: The Gruesome
Stock price: 0.13286713286713286
Shares outstanding: 349709027
Book value: 18427144.05594406
P/B ratio: 2.5215429810598646
Market cap (USD): 46464835.755244754
Debt to equity: 0
Current ratio: 7.601820790777876
Quick ratio: 7.601820790777876
COGS to revenue (%): 0
SG&A to revenue (%): 439.26767919202774
Free cash flow (dilution-adjusted): -1188411.1888111888
Buyback yield (%): 0
Retained earnings: -78862935.66433567
Receivables turnover: 0.2585114039659494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.7307801018382123
FCF margin (%): -3263.0479445479154
Rule of 40 score: -3263.0479445479154
Financial ratios for EOG.V — quarterly report dated 2025-03-31
Total revenue: -41672.72727272727
Operating income: -1439209.090909091
Net income: 975618.1818181819
Capital expenditures: 274326.5734265734
Operating cash flow: -664772.7272727273
Net tangible assets: 2753387.4125874126
Owner earnings: 701291.6083916085
Return on net tangible assets (%): 25.470139261390422
Buffett classification: The Gruesome
Stock price: 0.1188811188811189
P/E ratio: 10.653194350865222
Shares outstanding: 349709027
Book value: 14254977.622377623
P/B ratio: 2.916440945324558
Market cap (USD): 41573800.41258742
Debt to equity: 0
Current ratio: 4.340171447719474
Quick ratio: 4.340171447719474
Effective tax rate (%): 0
Free cash flow (dilution-adjusted): -963302.097902098
Buyback yield (%): 0
Retained earnings: -69977010.48951049
Receivables turnover: -0.22423998404521522
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.096186251810066
Revenue growth (%): -214.4217660951211
Rule of 40 score: -214.4217660951211
Financial ratios for EOG.V — annual report dated 2025-03-31
Total revenue: 0
Operating income: -3995334.9650349654
Net income: -1592691.6083916086
Capital expenditures: 5204600.6993007
Operating cash flow: -3858853.8461538465
Net tangible assets: 2753387.4125874126
Owner earnings: -6797292.307692308
Return on net tangible assets (%): -246.8701744119894
Buffett classification: The Gruesome
Stock price: 0.1188811188811189
Shares outstanding: 349709027
Book value: 14254977.622377623
P/B ratio: 2.916440945324558
Market cap (USD): 41573800.41258742
Debt to equity: 0
Current ratio: 4.340171447719474
Quick ratio: 4.340171447719474
Free cash flow (dilution-adjusted): -4157383.216783217
Buyback yield (%): 0
Retained earnings: -69977010.48951049
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.027648102113073
Rule of 40 score: 0
Financial ratios for EOG.V — quarterly report dated 2025-06-30
Total revenue: 1544.5255474452554
Operating income: -1138775.9124087591
Net income: -1135253.2846715327
Capital expenditures: 164233.57664233574
Operating cash flow: -642117.5182481752
Net tangible assets: 1664659.1240875912
Owner earnings: -1299486.8613138683
Return on net tangible assets (%): -78.06324084674839
Buffett classification: The Gruesome
Stock price: 0.1313868613138686
Shares outstanding: 349709027
Book value: 13834202.189781021
P/B ratio: 3.3212736665506415
Market cap (USD): 45947171.430656925
Debt to equity: 0
Current ratio: 2.4989378665050683
Quick ratio: 2.4989378665050683
COGS to revenue (%): 0
SG&A to revenue (%): 17806.852551984874
Free cash flow (dilution-adjusted): -909321.1678832116
Buyback yield (%): 0
Retained earnings: -74176950.3649635
Receivables turnover: 0.01647269471799463
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.231598011845918
FCF margin (%): -58873.81852551985
Rule of 40 score: -58873.81852551985
Financial ratios for EOG.V — quarterly report dated 2025-09-30
Total revenue: 1522.3021582733813
Operating income: -1188098.5611510791
Net income: -1190513.6690647483
Capital expenditures: 161870.50359712233
Operating cash flow: -1109054.6762589929
Net tangible assets: 642910.7913669065
Owner earnings: -1352384.1726618707
Return on net tangible assets (%): -210.35331663768432
Buffett classification: The Gruesome
Stock price: 0.11510791366906475
Shares outstanding: 349709027
Book value: 12637352.517985612
P/B ratio: 3.185340951114431
Market cap (USD): 40254276.48920864
Debt to equity: 0
Current ratio: 1.6550677171449433
Quick ratio: 1.6550677171449433
COGS to revenue (%): 0
SG&A to revenue (%): 31747.826086956524
Free cash flow (dilution-adjusted): -1140609.3525179857
Buyback yield (%): 0
Retained earnings: -74300169.78417267
Receivables turnover: 0.01668427609480706
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.401483099091877
FCF margin (%): -74926.606805293
Revenue growth (%): -1.4388489208633
Rule of 40 score: -74928.04565421387
Financial ratios for EOG.V — quarterly report dated 2025-12-31
Total revenue: 1459.875912408759
Operating income: 657524.8175182481
Net income: 659316.7883211678
Capital expenditures: 0
Operating cash flow: 768105.8394160584
Net tangible assets: 1342462.7737226277
Owner earnings: 659316.7883211678
Return on net tangible assets (%): 49.11248201638344
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.3722627737226277
P/E ratio: 49.36308869001754
Shares outstanding: 349709027
Book value: 13621494.890510948
P/B ratio: 9.557222128207842
Market cap (USD): 130183652.38686131
Debt to equity: 0
Current ratio: 2.4541085947951156
Quick ratio: 2.4541085947951156
COGS to revenue (%): 0
SG&A to revenue (%): 30195.597066044007
Free cash flow (dilution-adjusted): 617678.102189781
Buyback yield (%): 0
Retained earnings: -74725527.00729926
Receivables turnover: 0.023674877780276753
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.827112022604033
FCF margin (%): 42310.31534526983
Revenue growth (%): -4.100778910766782
Rule of 40 score: 42306.21456635906
Financial ratios for EPOW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.16
Shares outstanding: 32161978
Market cap (USD): 37307894.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPOW — annual report dated 2022-12-31
Total revenue: 5477825.862068965
Gross profit: -194019.8275862069
Operating income: -2321711.6379310344
Net income: -3252388.2183908047
Capital expenditures: 6280775.143678161
Operating cash flow: -1375488.6494252873
Depreciation & amortization: 345058.0459770115
Net tangible assets: 2102655.3160919542
Owner earnings: -9188105.316091955
Return on net tangible assets (%): -436.9762959137396
Buffett classification: The Gruesome
Stock price: 2.73
Shares outstanding: 32161978
Book value: 10540459.33908046
P/B ratio: 8.330016474183353
Market cap (USD): 87802199.94
Debt to equity: 0.15896899027429842
Current ratio: 1.7152929982944225
Quick ratio: 1.010908317480641
Interest coverage ratio: -595.6617885579475
COGS to revenue (%): 103.54191302300593
R&D to revenue (%): 2.7642322227639395
SG&A to revenue (%): 36.07767082271188
Free cash flow (dilution-adjusted): -8102013.505747126
Buyback yield (%): 0
Retained earnings: -895753.8793103448
Inventory turnover: 2.153569817674527
Receivables turnover: 5.923444185120817
Capitalized R&D asset: 151419.8275862069
ROCI (R&D-adjusted, %): -18.837288828532632
FCF margin (%): -147.90564194180155
Rule of 40 score: -147.90564194180155
Financial ratios for EPOW — annual report dated 2023-12-31
Total revenue: 6336203.23488045
Gross profit: -1744479.746835443
Operating income: -3850708.5794655415
Net income: -3408239.0998593527
Capital expenditures: 1006745.8509142053
Operating cash flow: -1024331.223628692
Depreciation & amortization: 634308.2981715893
Net tangible assets: -999947.6793248944
Owner earnings: -3780676.652601969
Buffett classification: The Gruesome
Stock price: 1.08
Shares outstanding: 32161978
Book value: 6375775.527426159
P/B ratio: 5.4479546983082345
Market cap (USD): 34734936.24
Debt to equity: 0.6127330054925726
Current ratio: 0.5641327367772812
Quick ratio: 0.3145825589794976
Interest coverage ratio: -12.662885173689208
COGS to revenue (%): 127.53194116678861
R&D to revenue (%): 2.648326912932303
SG&A to revenue (%): 30.592854825611443
Free cash flow (dilution-adjusted): -2332877.4964838256
Buyback yield (%): 0
Retained earnings: -4285095.218002813
Inventory turnover: 3.626312947871644
Receivables turnover: 3.501333253747695
Capitalized R&D asset: 269254.6600101848
ROCI (R&D-adjusted, %): -45.71827698040768
Rosenberg metric: -10.23947751074094
FCF margin (%): -36.81822394271484
Revenue growth (%): 15.67003761027331
Rule of 40 score: -21.148186332441526
Financial ratios for EPOW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -2675912.0547945206
Buffett classification: The Gruesome
Stock price: 0.86
Shares outstanding: 32161978
Book value: 3738996.301369861
P/B ratio: 7.397520310428344
Market cap (USD): 27659301.08
Debt to equity: 1.8501708373644936
Current ratio: 0.726294788677137
Quick ratio: 0.5227323142609228
Buyback yield (%): 0
Retained earnings: -5786775.7534246575
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPOW — annual report dated 2024-12-31
Total revenue: 8903800.136986302
Gross profit: -794189.0410958905
Operating income: -2273469.589041096
Net income: -1613210.410958904
Capital expenditures: 337659.5890410959
Operating cash flow: -733172.1917808219
Depreciation & amortization: 783376.4383561644
Net tangible assets: -2675912.0547945206
Owner earnings: -1167493.5616438356
Buffett classification: The Gruesome
Stock price: 0.86
Shares outstanding: 32161978
Book value: 3738996.301369861
P/B ratio: 7.397520310428344
Market cap (USD): 27659301.08
Debt to equity: 1.8501708373644936
Current ratio: 0.726294788677137
Quick ratio: 0.5227323142609228
Interest coverage ratio: -8.221376344938276
COGS to revenue (%): 108.91966383877865
R&D to revenue (%): 3.8575556033555065
SG&A to revenue (%): 12.756480259829337
Free cash flow (dilution-adjusted): -1204084.2465753425
Buyback yield (%): 0
Retained earnings: -5786775.7534246575
Inventory turnover: 4.0087065461181774
Receivables turnover: 1.9967694526664712
Capitalized R&D asset: 505865.84580271423
ROCI (R&D-adjusted, %): -26.18704667599221
Rosenberg metric: 5.663120320152528
FCF margin (%): -13.523262293069537
Revenue growth (%): 40.52264119262104
Rule of 40 score: 26.999378899551502
Financial ratios for EPOW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -3344211.436541144
Buffett classification: The Gruesome
Stock price: 0.88
Shares outstanding: 32161978
Book value: 3524847.2803347297
P/B ratio: 8.029437416452353
Market cap (USD): 28302540.64
Debt to equity: 3.5491493246490182
Current ratio: 0.8291074695235776
Quick ratio: 0.5518578863871458
Buyback yield (%): 0
Retained earnings: -6067574.616457461
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERL.AX — annual report dated 2021-06-30
Operating income: -1804865.4135338345
Net income: -809230.8270676691
Capital expenditures: 0
Depreciation & amortization: 1666.1654135338345
Net tangible assets: 2288938.3458646615
Owner earnings: -807564.6616541353
Return on net tangible assets (%): -35.281188901969855
Buffett classification: The Gruesome
Stock price: 0.007518796992481203
Shares outstanding: 2087141555
Book value: 2288938.3458646615
P/B ratio: 6.855926755287279
Market cap (USD): 15692793.64661654
Debt to equity: 0.5265418383543213
Current ratio: 2.4370340152504313
Quick ratio: 2.4370340152504313
Interest coverage ratio: -21.33752
Free cash flow (dilution-adjusted): -1477894.7368421052
Buyback yield (%): 0.3451946027685697
Retained earnings: -18174752.631578945
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -78.85163952950576
Rule of 40 score: 0
Financial ratios for ERL.AX — annual report dated 2022-06-30
Operating income: -1627161.3793103448
Net income: -1829822.7586206896
Capital expenditures: 0
Depreciation & amortization: 883.448275862069
Net tangible assets: 1279206.8965517243
Owner earnings: -1828939.3103448276
Return on net tangible assets (%): -142.97447232929886
Buffett classification: The Gruesome
Stock price: 0.006896551724137932
Shares outstanding: 2087141555
Book value: 1279206.8965517243
P/B ratio: 11.252346847453971
Market cap (USD): 14394079.689655174
Debt to equity: 0
Current ratio: 11.142842199147736
Quick ratio: 11.142842199147736
Interest coverage ratio: -121.7872296495122
Free cash flow (dilution-adjusted): -1830400.6896551724
Buyback yield (%): 0.4506690012216253
Retained earnings: -18500457.931034483
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -127.20079790818663
Rule of 40 score: 0
Financial ratios for ERL.AX — annual report dated 2023-06-30
Operating income: -963776.821192053
Net income: -943145.6953642385
Capital expenditures: 0
Depreciation & amortization: 831.7880794701987
Net tangible assets: 599237.0860927153
Owner earnings: -942313.9072847683
Return on net tangible assets (%): -157.25226778420242
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 2087141555
Book value: 599237.0860927152
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 7.619999414708378
Quick ratio: 7.619999414708378
Free cash flow (dilution-adjusted): -878824.5033112583
Retained earnings: -18708486.09271523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -160.83397432496952
Rule of 40 score: 0
Financial ratios for GAUZ — quarterly report dated 2024-09-30
Total revenue: 6285945.945945946
Gross profit: 1504864.8648648649
Operating income: -2362162.162162162
Net income: -1485675.6756756755
Capital expenditures: 723783.7837837838
Operating cash flow: -3977297.297297297
Depreciation & amortization: 449729.7297297297
Net tangible assets: 4087837.8378378376
Owner earnings: -1759729.7297297297
Return on net tangible assets (%): -43.04793388429752
Buffett classification: The Gruesome
Stock price: 8.85
Shares outstanding: 18743137
Book value: 15768918.918918919
P/B ratio: 10.51922223095381
Market cap (USD): 165876762.45
Debt to equity: 0.8102493786956895
Current ratio: 1.164373599591179
Quick ratio: 0.8480286174771021
Interest coverage ratio: -7.048387096774192
COGS to revenue (%): 76.05985037406484
R&D to revenue (%): 19.85553357984349
SG&A to revenue (%): 37.20010319030011
Free cash flow (dilution-adjusted): -4987297.297297297
Buyback yield (%): 0
Retained earnings: -57746216.216216214
Inventory turnover: 1.0990990990990992
Receivables turnover: 1.151899361101481
Capitalized R&D asset: 1248108.108108108
ROCI (R&D-adjusted, %): -5.758830330834359
FCF margin (%): -79.34044199845215
Rule of 40 score: -79.34044199845215